SYNKAYVITE Drug Patent Profile
✉ Email this page to a colleague
When do Synkayvite patents expire, and when can generic versions of Synkayvite launch?
Synkayvite is a drug marketed by Roche and is included in one NDA.
The generic ingredient in SYNKAYVITE is menadiol sodium diphosphate. There is one drug master file entry for this compound. Additional details are available on the menadiol sodium diphosphate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SYNKAYVITE?
- What are the global sales for SYNKAYVITE?
- What is Average Wholesale Price for SYNKAYVITE?
Summary for SYNKAYVITE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| DailyMed Link: | SYNKAYVITE at DailyMed |
US Patents and Regulatory Information for SYNKAYVITE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | SYNKAYVITE | menadiol sodium diphosphate | INJECTABLE;INJECTION | 003718-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roche | SYNKAYVITE | menadiol sodium diphosphate | TABLET;ORAL | 003718-010 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roche | SYNKAYVITE | menadiol sodium diphosphate | INJECTABLE;INJECTION | 003718-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Roche | SYNKAYVITE | menadiol sodium diphosphate | INJECTABLE;INJECTION | 003718-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
